Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

Tag Archives: R

Duloxetine’s Effect on Blood Glucose Levels...
October 1, 2012 - Clinical , Featured

By: Neal Shah, Co-Editor-in-Chief – Duloxetine is a serotonin (5HT) and norepinephrine (NE) reuptake inhibitor (SNRI) introduced to the US market in 2004, indicated for the treatment of diabetic neuropathic pain.1 A chemical figure of duloxetine is shown [in the PDF].2 It was developed in an effort to mimic tricyclic antidepressant mitigation of neuropathic pain…

The Role of NMDA in Electroconvulsive Therapy and Other...
October 1, 2012 - Clinical , Featured

By: Neal Shah, Co-Editor-in-Chief – Electroconvulsive therapy (ECT) is a last-line procedure in the treatment of refractory depression, among other neuropsychological disorders.1 By inducing a seizure, neurotransmitters are released and the disease state may feature a modest mitigation in symptoms.1 Seizure medications such as benzodiazepines and barbiturates are prescribed to increase or heighten the seizure…

Bisphosphonates and Atypical Fracture Risk...
September 1, 2012 - Clinical , Featured

By: Steve Soman, Pharm.D. Candidate c/o 2013 – Bisphosphonates are proven to enhance bone density and reduce fracture incidence in post-menopausal women but recent data suggests they may have adverse effects with regards to bone quality.  The drugs in this class can be differentiated as non-nitrogen containing (older generation) and nitrogen containing (newer generation) medications.…

Quick Update: Triptan Pharmacology...
August 1, 2012 - Clinical

By: Neal Shah, Co-Editor-In-Chief – Migraines can be “classic” or “common.”  While all migraines feature unilateral, pulsating headaches, classic migraines feature an “aura” upon onset (whereas common migraines do not).  Pharmacologic treatment of migraines generally includes serotonin agonists (triptans).1 Triptans are selective agonists of the 5-hydroxytryptamine 1B and 1D (5HT1B/1D) subtypes.  By activating these receptors,…

Puzzle: Word Search...
August 1, 2012 - Puzzles

By: Marie Huang –  A A A X R Z B D R P L A A D B E N S O L N A O L D B N N I L M E U R S E M N N E S E I D U A U O K S E…

Puzzle: Word Search...
July 1, 2012 - Puzzles

By: Marie Huang –  S A O N Z O A D B W Y S K W M I E E R T L R J R A O J C A S S A G N O L N L O K C A A Y J R D C M O I…

Understanding Diabetic Ketoacidosis...
July 1, 2012 - Clinical , Featured

By: Mohamed Dungersi, Associate Student Editor –  What is diabetic ketoacidosis (DKA)? Diabetic ketoacidosis (DKA) is an acute complication of uncontrolled diabetes or hyperglycemia. It is usually observed in cases of extreme hyperglycemia (usually in excess of 500 mg/dl, though it can occur over 250 mg/dl).1,2  It is usually characterized by the presence of hyperglycemia,…

The Pathology of Pure Red Cell Aplasia...
July 1, 2012 - Clinical

By: Neal Shah, Co Editor-In-Chief – Pure Red Cell Aplasia (PRCA), also known as erythroblastopenia, is characterized by a suppression of erythrocytes in the bone marrow.  It is a peculiar oddity that the bone marrow’s progenitor cells still differentiate into white blood cells and platelets.1  PRCA has idiopathic, viral, auto-immune, and genetic etiologies.  Diamond-Blackfan syndrome…

Five Lessons Learned from Being an Assistant Dean...
June 1, 2012 - Featured , Professional Advice / Opinions

By: Laura Gianni Augusto, B.S., Pharm.D., Associate Clinical Professor, Department of Clinical Pharmacy Practice – Laura Gianni Augusto, Pharm.D., R.Ph. is an Associate Clinical Professor in the Department of Clinical Pharmacy Practice at St. John’s University College of Pharmacy and Health Sciences. She served as Assistant Dean for Experiential Pharmacy Education from 2007 to 2011.…

Impact of Gender and Race on the Efficacy on Opiods...
June 1, 2012 - Clinical , Featured

By: Lunbao (Jerry) Huang, Pharm.D.  Candidate c/o 2013 – Pain is a very difficult condition to manage, as clinicians have only subjective findings to work with.  Opioid medications are currently the cornerstones for the management of moderate to severe pain; however, it is often problematic to determine a patient’s real ‘need’ for opioids.  Physicians’ clinical…

Puzzle: Word Search...
June 1, 2012 - Puzzles

By: Marie Huang  – C F E P I A I I M L R O I I M I T I T M I I Y L G N C E F T A Z I D I M E T L E N I C A K I M A N V O…

Effect of Intravenous Ondansetron on QT Interval Prolon...
June 1, 2012 - Clinical

By: Raymond Wu, Pharm.D. Candidate c/o 2013   The 5-hydroxytryptamine type 3 (5HT3) antagonists (e.g. ondansetron [Zofran®]) are commonly used in the prevention and treatment of nausea and vomiting in the inpatient setting.1  Overall, ondansetron is a well-tolerated medication with few side effects.1  Constipation, dizziness, and headache are the most commonly reported side effects associated…

Puzzle: Word Search...
May 1, 2012 - Puzzles

By: Marie Huang –  G A L K N Y L O M O R C B U A O E B R C A T H E O R A Z R T L H N R Y T S N A I E A O I P S L I E R E…

Role of Calcium Channel Blockers and Beta Blockers in C...
May 1, 2012 - Clinical , Featured

By: Lunbao Huang Pharm D. Candidate c/o 2013 – The seventh report of the Joint National Committee on high blood pressure (JNC-7) states that most classes of antihypertensive drugs such as angiotensin converting enzyme inhibitors (ACEIs), angiotensin-II receptor blockers (ARBs), beta-blockers (BBs), diuretics, and aldosterone-receptor antagonists can be used for hypertensive heart failure patients except…

Sativex®: A Realistic Option for Advanced Cancer Pain?...
April 1, 2012 - Clinical , Featured , In the News / Politics

By: Kathlynn Ferrer, Pharm.D. Candidate c/o 2013 – Nabiximols (Sativex®) is a buccal spray that has been approved for use in the UK, Spain, Germany, Denmark, New Zealand, and Canada. The active ingredients in this product are Tetrahydrocannabinol and Cannabidiol, two kinds of cannabinoids1. Cannabinoids are chemical compounds that stimulate cannabinoid receptors and are the…

Puzzle: Word Search...
April 1, 2012 - Puzzles

By: Marie Huang –  M C O N E E E Y L O N E L U L M D N F T I E C S M M A O E L L N N L O U N F I N U I E N I N E O E T A…

Featured Organization: Urban Santa Project (USP)...
April 1, 2012 - Professional Advice / Opinions

By: Sibyl Cherian, PharmD Candidate c/o 2013 – Santhosh Cherian, is the co-founder and executive director of the Urban Humanitarian Projects (UHP). He is currently in his third year of medical school at St. George University and is completing his clinical clerkships in Brooklyn, New York. St. John’s University is a Catholic, Vincentian and metropolitan…

I-STOP: The New Front Against Prescription Drug Abuse...
March 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – As previously reported, the recent rise in violence against pharmacies (by people in search of narcotic medications) has riled the New York State legislature into action.  The attorney general has also joined the fray in the fight against prescription drug abuse.  Last June, Attorney General Eric T. Schneiderman, proposed setting…

CHF, a Rare but Serious Presentation of Graves’ disea...
March 1, 2012 - Clinical , Featured

By: James Schurr, Pharm.D. Candidate c/o 2014 – Graves’ disease is an autoimmune disorder that results in a state of thyrotoxicosis, or a cause of hyperthyroidism, due to the Immunoglobulin G-mediated agonism of thyroid stimulating hormone (TSH) receptors located on the thyroid.  Stimulation of TSH receptors causes an increase in circulating thyroxine (T4) and triiodothyronine…

Puzzle: Word Search...
March 1, 2012 - Puzzles

By: Marie Huang –  E M E L I T H I U M U O E L L E N I S S A T U E Z L A Z I N I L E L I N A G A M P I Z O T E A I L A T…

Proton Pump Inhibitors and the Treatment of Osteoporosi...
February 1, 2012 - Clinical , Featured

By: Neal Shah – Osteoporosis is a disease of the bone characterized by decreased bone mineral density (BMD), which reduces the ability of bone to provide adequate structural support.  The main cause of this decreased BMD is inadequate calcium intake or absorption.  The decreased BMD can cause diffuse lesions throughout the skeletal system and can…

Bydureon®: A Weekly Injection for Type 2 Diabetes Mell...
February 1, 2012 - Clinical , Featured , In the News / Politics

By: Mohamed Dungersi – On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus (T2DM), as an adjunct to diet and exercise.  Bydureon®, a product of Amylin Pharmaceuticals, is a modified formulation of the twice-daily injection, Byetta® (exenatide).  It is the first once-a-week medication for T2DM in the market.…

Puzzle: Word Search...
February 1, 2012 - Puzzles

By: Marie Huang –  H N N E O L P A A R I A P E E A A E P T E R I L A S E S N N I R I P S A R H C A N H R O A A H L I P L…

New Oral Direct Thrombin Inhibitors and Factor Xa Antic...
January 1, 2012 - Clinical , Featured , In the News / Politics

By: Neal Shah – Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein thrombosis, stroke, pulmonary embolism, myocardial infarction, and atrial fibrillation.1  Intravenous medications, such as unfractionated heparin (UFH), low molecular weight heparin (LMWH), and direct thrombin inhibitors (DTI), are commonly used in, both, inpatient and outpatient settings.…

Puzzle: Word Search...
January 1, 2012 - Puzzles

By: Marie Huang –  P S E D S Z M L N I I I N L N E I I I A S V I M P I I D N O M G P Z O I R L I A I I O V R O A A E I R…

New York Lawmakers Tackle Prescription Drug Abuse...
January 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – We have all heard the mortifying tales of recent attacks on pharmacies by addicts looking to steal prescription pain-killers. Most notable perhaps, was the case of David Laffers. Mr. Laffers walked into Haven Drugs in Medford, NY and killed the pharmacist, a store clerk, and two customers, who happened to…

Differences Between Antagonists and Inverse Agonists...
December 1, 2011 - Clinical

By: Neal Shah – There are two major classifications of drug-receptor activity: agonism and antagonism. Agonism occurs when a molecule binds to a receptor, causes an exertion of normal receptor operation, and eventually causes a response. Antagonism of a receptor occurs when a molecule binds to the receptor and does not allow activity to occur.1…

Ivabradine: A Novel I(f) Blocker for Stable Angina...
December 1, 2011 - Clinical

By: Neal Shah – Part I:              Preface. Part II:             Brief review of cardiac electrophysiology. Part III:           Ivabradine as a novel If blocker for the use of stable angina. Part IV:           On the horizon: trimetazidine. – PREFACE When viewed anatomically, the heart may seem like a simple organ.  However, the electrophysiological aspects of the heart are…

Puzzle: Word Search...
December 1, 2011 - Puzzles

By: Marie Huang – A E N N E T D B I E O C T U M E N D D N A E L D R O I E I N E I I C I O T N N I E B I I A T M C Z D D…

Drug Shortages: Impacts and Prevention Measures...
December 1, 2011 - Featured , In the News / Politics , Professional Advice / Opinions

By: Jimmy Johnson, PharmD Candidate c/o 2012 – Drug shortages have become more and more of an issue in the health care industry. There are over 200 drugs on the Food and Drug Administration’s (FDA) drug shortage list – a number that has tripled in the last five years.1 The largest impact has been on anesthesia…

Faculty Spotlight: Dr. Charles R. Ashby...
December 1, 2011 - Featured , Professional Advice / Opinions

By: Neal Shah – Dr. Ashby is a well-known Pharmacology professor for student pharmacists studying in their professional years. He graduated from the University of Louisville with a BA in Biology and Psychology in 1983. After obtaining his PhD in Pharmacology from the University of Louisville in 1987, he continued his education by obtaining a…

Federal Government to Attempt Limiting Drug Shortages...
December 1, 2011 - In the News / Politics

By: Mahdieh Danesh Yazdi, with special thanks to Dr. Tomasz Jodlowski – Drug shortages have plagued health care institutions in recent years; they present a serious problem to health care delivery on a national scale. In 2004, there were 58 drug shortages; now, in 2011, this number has increased to 198. Due to limited access…

Puzzle: Word Search...
November 1, 2011 - Puzzles

By: Marie Huang – M E N E P I R O D L L R T K R O N E O M R I E F E N I V T I I L N K L A X Z S N V I O E O M Y A I I O…

Letter to the Editor: An Answer to the Rising Drug Cost...
November 1, 2011 - Professional Advice / Opinions

By: Dr. Olga Hilas – Foreword: Dr. Olga Hilas is an Associate Clinical Professor at Saint John’s University and a Clinical Pharmacy Manager in internal medicine and geriatrics at Weill Cornell Medical Center. Dr. Hilas agreed to provide feedback to in response to Ebey’s article entitled, “Big Pharma vs. Developing Countries: Debating Generic Drugs and…

In The News: TNF-Alpha Inhibitors Receive More Warnings...
October 1, 2011 - In the News / Politics

By Ebey P. Soman – TNF-alpha inhibitors are drugs used to treat rheumatoid arthritis, Crohn’s disease, and ulcerative colitis, as well as other disease states. These agents suppress the immune system and increase the risk of developing serious infections. Currently, there are five approved drugs in this category: • Adalimumab (Humira®, Abbott) • Certolizumab pegol…

Faculty Spotlight: Dr. Parnali Chatterjee...
October 1, 2011 - Featured , Professional Advice / Opinions

By: Ebey P. Soman – Meet Dr. Parnali Chatterjee, a new faculty member in our St. John’s University family. I had the opportunity to meet Dr. Chatterjee at the doctoral seminar hosted by Dr. Lin Mantell entitled, “Drug Metabolism and Pharmacokinetics in Drug Discovery and Development.” I was introduced to Dr. Chatterjee through Dr. Frank…

The Industry: Generics Drugs and Intellectual Property ...
October 1, 2011 - Featured , Professional Advice / Opinions

By: Ebey P. Soman – The World Trade Organization (WTO) and its member nations met in Uruguay in 1994 to establish international norms for trade, economy, and development. They developed the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which provided patent protection for pharmaceutical companies to make brand name medications and market those…

Post navigation

Newer posts →


Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post